Tag: project

LAS VEGAS, July 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- Golden Triangle Ventures, Inc. (OTC PINK: GTVH) ("GTV" or the "Company") is pleased to announce the completion of a significant restructuring of its legacy debt obligations and capital structure. The Company has now executed a definitive agreement with a third-party investor who has acquired all outstanding notes previously held by its largest creditor, T&K Zarro, LLC. This strategic investor has expressed strong alignment with the Company's long-term vision and is committed to supporting its continued growth.

As part of the transaction, Golden Triangle Ventures and T&K Zarro, LLC have executed and closed an agreement transferring five outstanding debt instruments—representing more than $7 million in total obligations—to the new private investor. The closing was subject to several corporate actions, including an increase in the Company’s authorized share capital. In connection with the transaction, GTVH secured a fixed price repurchase right from the new investor, granting the Company the exclusive option to reacquire the full balance of the notes, at any time, for a total of $4 million. This represents a significant discount and provides a pathway to eliminate the debt under favorable terms.

FREMONT, Calif, July 01, 2025 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced that it has entered into definitive agreements for the issuance and sale of 1,626,019 shares of its common stock, Series A-3 warrants to purchase up to an aggregate of 1,626,019 shares of common stock and short-term Series A-4 warrants to purchase up to an aggregate of 3,252,038 shares of common stock, at a purchase price of $0.615 per share and associated warrants in a private placement priced at-the-market under Nasdaq rules.

Financing co-led by Ferring Ventures S.A. and Apeiron Investment Ltd. with participation from new and existing healthcare-focused institutional investors, including Ally Bridge Group and ADAR1